Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
32273924 | 0 | Siddiqui NA, Moosa MA, Shaikh FA, et al. Predictors of Poor Quality of Life after Primary Lower Limb Deep Venous Thrombosis: A Perspective from a Developing Nation. Ann Vasc Dis. 2020 Mar 25;13(1):63-68. doi: 10.3400/avd.oa.19-00126. | |
31543350 | 0 | Sophie R, Wang PW, Channa R, et al. Different Factors Associated with 2-Year Outcomes in Patients with Branch versus Central Retinal Vein Occlusion Treated with Ranibizumab. Ophthalmology. 2019 Dec;126(12):1695-1702. doi: 10.1016/j.ophtha.2019.07.018. Epub 2019 Jul 23. | |
31455483 | 0 | Rehman ZU, Durrani MY, Ishaq H, et al. Distal Revascularization and Interval Ligation as a Useful Option for Steal Syndrome. J Coll Physicians Surg Pak. 2019 Sep;29(9):865-867. doi: 10.29271/jcpsp.2019.09.865. | |
30017909 | 0 | Salma N, Julie L, Boutahar B, et al. Thrombotic risk assessment and analytical performance of the chemiluminescent analyzer IDS-iSYS for the detection of anti-cardiolipin and anti-beta 2 glycoprotein I autoantibodies. Clin Immunol. 2018 Sep;194:92-99. doi: 10.1016/j.clim.2018.07.006. Epub 2018 Jul 11. | |
27083699 | 0 | Siddiqui NA, Sophie Z, Zafar F, et al. Predictors for the development of post-thrombotic syndrome in patients with primary lower limb deep venous thrombosis: A case-control study. Vascular. 2017 Feb;25(1):10-18. doi: 10.1177/1708538116636250. Epub 2016 Jul 10. | |
26712560 | 0 | Mir TA, Kherani S, Hafiz G, et al. Changes in Retinal Nonperfusion Associated with Suppression of Vascular Endothelial Growth Factor in Retinal Vein Occlusion. Ophthalmology. 2016 Mar;123(3):625-34.e1. doi: 10.1016/j.ophtha.2015.10.030. Epub 2015 Dec 19. | |
26482397 | 0 | Campochiaro PA, Hafiz G, Mir TA, et al. Reply. Am J Ophthalmol. 2016 Jan;161:216-7. doi: 10.1016/j.ajo.2015.09.034. Epub 2015 Oct 23. | |
25972260 | 0 | Campochiaro PA, Hafiz G, Mir TA, et al. Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial. Ophthalmology. 2015 Jul;122(7):1426-37. doi: 10.1016/j.ophtha.2015.04.006. Epub 2015 May 9. | |
25908486 | 0 | Campochiaro PA, Hafiz G, Mir TA, et al. Pro-Permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; the Ozurdex for Retinal Vein Occlusion (ORVO) Study. Am J Ophthalmol. 2015 Aug;160(2):313-321.e19. doi: 10.1016/j.ajo.2015.04.025. Epub 2015 Apr 20. |